Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Solid Biosciences Inc. | Director | Common Stock | 110K | $842K | $7.67 | Oct 3, 2024 | Direct |
Foghorn Therapeutics Inc. | Director | Stock Options (Right to buy) | 16K | $88.3K | $5.52 | Jun 26, 2024 | Direct |
Solid Biosciences Inc. | Director | Restricted Stock Units | 3.26K | $25K | $7.67 | Oct 3, 2024 | Direct |
Solid Biosciences Inc. | Director | Director Stock Option (Right to Buy) | 34.4K | Jun 11, 2024 | Direct | ||
Solid Biosciences Inc. | Director | Stock Option (Right to Buy) | 15.1K | Jan 3, 2024 | Direct | ||
Stoke Therapeutics, Inc. | Director | Director Stock Option (Right to Buy) | 7.64K | Jun 5, 2024 | Direct |